SALLY BROOKS: Open Payments
NPI 1104476829 · WINNSBORO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 35 payments from 9 companies in 2025. Trend: 2023 $373 · 2024 $563 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $241 |
| Vanda Pharmaceuticals Inc. | 6 | $156 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Janssen Pharmaceuticals, Inc | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Corium, LLC | 2 | $54 |
| ABBVIE INC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
Products named: Qelbree, FANAPT, REXULTI, Auvelity, INVEGA SUSTENNA, Azstarys, VRAYLAR, COBENFY.
Industry payments across LA — which companies pay providers there.
